Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)Looking for participantsNCT07748988
What this trial is testing

Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Refractory Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma
Vanderbilt-Ingram Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Not applicableStudy completedNCT00900042
What this trial is testing

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 34
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT01571401
What this trial is testing

Trying Activity in Kidney Cancer Survivors (TRACKS) Trial

Who this might be right for
Supervised Physical Activity Plus Exercise CounselingSupervised Physical Activity Plus Behavioural Counseling
University of Alberta 32
Not applicableStudy completedNCT01908166
What this trial is testing

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

Who this might be right for
Adult Primary Liver CancerKidney Tumor
Stanford University 61
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Not applicableUnknownNCT02208128
What this trial is testing

Molecular Determinants for Therapy Response on Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Heidelberg University 4
Early research (Phase 1)Study completedNCT00886353
What this trial is testing

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Who this might be right for
Pulmonary DiseasesCardiovascular DiseasesKidney Diseases+1 more
Apeiron Biologics 22
Not applicableLooking for participantsNCT06908902
What this trial is testing

Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal Tumors

Who this might be right for
RCC, Renal Cell CancerPartial Nephrectomy
The First Affiliated Hospital with Nanjing Medical University 60
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Not applicableStudy completedNCT01002937
What this trial is testing

Novel Prognostic Markers in Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Royal Marsden NHS Foundation Trust 182
Testing effectiveness (Phase 2)Study completedNCT00005045
What this trial is testing

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Not applicableUnknownNCT04424472
What this trial is testing

Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas Medical Center 50
Not applicableWithdrawnNCT01642095
What this trial is testing

Studying Biomarkers in Samples From Younger Patients With Kidney Cancer

Who this might be right for
Childhood Kidney NeoplasmClear Cell Renal Cell CarcinomaCongenital Mesoblastic Nephroma+1 more
Children's Oncology Group
Large-scale testing (Phase 3)Not Yet RecruitingNCT07338981
What this trial is testing

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

Who this might be right for
Advanced Kidney Cancer
Guliz Ozgun 142
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Not applicableEnrolling By InvitationNCT00102544
What this trial is testing

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Who this might be right for
AdenocarcinomaProstate NeoplasmsProstate Cancer+2 more
National Institutes of Health Clinical Center (CC) 3,894
Testing effectiveness (Phase 2)Study completedNCT00079612
What this trial is testing

Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer

Who this might be right for
Carcinoma, Renal Cell
Bayer 501
Next Page